XM does not provide services to residents of the United States of America.

Zelenskiy urges speedy passage of Ukraine aid in US Senate, transfer of weapons



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 3-Zelenskiy urges speedy passage of Ukraine aid in US Senate, transfer of weapons</title></head><body>

Adds weapons details in paragraphs 6-7 and 14-15, comments from Senator Warner in 12-13

By Humeyra Pamuk

WASHINGTON, April 21 (Reuters) -Ukrainian President Volodymyr Zelenskiy on Sunday welcomed the passage of $60 billion in aid for Ukraine by the U.S. House of Representatives but urged Washington to quickly turn the bill into law and proceed with the actual transfer of weapons, saying long-range arms and air defense systems were top priorities.

In an interview with NBC's "Meet the Press", Zelenskiy said the passage of the bill would send a powerful message to Russia that Washington stands by Kyiv and that it would not be "a second Afghanistan."

"I think this support will really strengthen the armed forces of Ukraine and we will have a chance for victory," Zelenskiy said through an interpreter.

During the interview he repeatedly urged U.S. lawmakers to take swift action to pass the bill in the Senate. He said Ukraine urgently needed U.S. long-range weapons including ATACMS (Army Tactical Missile Systems) and air defense systems to turn around its fortunes on the battlefield.

"This is crucial. These are the priorities now," Zelenskiy said.

ATACMS are long-range guided missiles. The White House last October confirmed that it had provided Kyiv with a type of ATACMS capable of hitting targets up to 165 km (102 miles) away.

Ukraine had repeatedly asked the U.S. administration for the ATACMS and pledged not to use them inside Russia's territory.

The U.S. House of Representatives, with broad bipartisan support, passed a $95 billion legislative package providing security assistance to Ukraine, Israel and Taiwan. Aid for Ukraine had been held up for months, because of the opposition of Republican presidential candidate Donald Trump, who urged Republican lawmakers to block it.

Almost 26 months since the 2022 invasion, Russia is slowly advancing in eastern Ukraine and has ramped up its bombardments of cities and towns behind the front lines amid a slowdown in Western military assistance.

The legislation now proceeds to the Democratic-majority Senate, which passed a similar measure more than two months ago. U.S. leaders, from Democratic President Joe Biden to top Senate Republican Mitch McConnell, had been urging Republican House Speaker Mike Johnson to bring it up for a vote.

The Senate is set to begin considering the bill on Tuesday, with some preliminary votes that afternoon. Final passage is expected sometime next week, which would clear the way for Biden to sign it into law.

WEAPONS IN TRANSIT NEXT WEEK

Senate Intelligence Committee Chair Mark Warner told CBS' "Face the Nation" that military equipment including the longer-range ATACMS should be "in transit by the end of the week".

"I believe the administration was prepared over the last couple of months to prepare or to provide ATACMS. It is written into this legislation," Warner said.

Ukraine last October said it has used the long-range missiles for the first time, inflicting heavy damage on two airfields in Russian-occupied areas.

Deploying the weapons would allow Ukrainian forces to disrupt previously unreachable supply lines, air bases and rail networks used by Russia in occupied territories, senior officials say.

Zelenskiy declined to provide a timeline when asked how long it would take Ukraine to "turn the corner on Russia" and whether Kyiv would need as much aid this time next year.

He said Kyiv had lost the initiative in the fighting in the eastern part of the country, but that once the weapons arrive it will have the chance to stabilize the situation.

"Giving U.S. specific timeline of the war, well, it depends on how soon we get this aid," he said.



Reporting by Humeyra Pamuk; Additional reporting by Kaniskha Singh and Ron Popeski; Editing by Chizu Nomiyama

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.